Enovis Corp last reported quarterly results on Nov 5, 2026, for Q3 FY2026 (the quarter ended Oct 2, 2026): revenue of $558.7 million (+1.8% year over year) and diluted EPS of $0.06. It usually reports 34–57 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 25, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Feb 26, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 34–57 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 5, 2026
34 days after quarter end
|
Q3 FY2026
ended Oct 2, 2026
|
559
+1.8%
|
3
+100.5%
|
0.06
+100.6%
|
|
Aug 6, 2026
34 days after quarter end
|
Q2 FY2026
ended Jul 3, 2026
|
583
+3.2%
|
-1
+96.8%
|
-0.02
+96.9%
|
|
May 7, 2026
34 days after quarter end
|
Q1 FY2026
ended Apr 3, 2026
|
589
+5.4%
|
-9
+84.3%
|
-0.15
+84.7%
|
|
Feb 26, 2026
57 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
576
+2.6%
|
-521
+26.0%
|
-9.10
+27.7%
|
|
Nov 6, 2025
34 days after quarter end
|
Q3 FY2025
ended Oct 3, 2025
|
549
+8.6%
|
-571
-1712.0%
|
-9.99
-1622.4%
|
|
Aug 7, 2025
34 days after quarter end
|
Q2 FY2025
ended Jul 4, 2025
|
565
+7.5%
|
-37
-97.1%
|
-0.64
-88.2%
|
|
May 8, 2025
34 days after quarter end
|
Q1 FY2025
ended Apr 4, 2025
|
559
+8.2%
|
-56
+22.3%
|
-0.98
+25.8%
|
|
Feb 26, 2025
57 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
561
+23.3%
|
-703
-23829.3%
|
-12.59
-23284.2%
|
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- ENOV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lewisville, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1420800
- Former names
- Colfax CORP (until Mar 18, 2022)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.